Exercise Testing in the Risk Assessment of Pulmonary Hypertension.

chronic obstructive exercise physical aerobic exercise pulmonary arterial hypertension pulmonary disease pulmonary hypertension right ventricular dysfunction

Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
09 2023
Historique:
received: 12 12 2022
revised: 04 04 2023
accepted: 09 04 2023
pmc-release: 01 09 2024
medline: 11 9 2023
pubmed: 16 4 2023
entrez: 15 4 2023
Statut: ppublish

Résumé

Right ventricular dysfunction in pulmonary hypertension (PH) contributes to reduced exercise capacity, morbidity, and mortality. Exercise can unmask right ventricular dysfunction not apparent at rest, with negative implications for prognosis. Among patients with pulmonary vascular disease, right ventricular afterload may increase during exercise out of proportion to increases observed among healthy individuals. Right ventricular contractility must increase to match the demands of increased afterload to maintain ventricular-arterial coupling (the relationship between contractility and afterload) and ultimately cardiac output. Impaired right ventricular contractile reserve leads to ventricular-arterial uncoupling, preventing cardiac output from increasing during exercise and limiting exercise capacity. Abnormal pulmonary vascular response to exercise can signify early pulmonary vascular disease and is associated with increased mortality. Impaired right ventricular contractile reserve similarly predicts poor outcomes, including reduced exercise capacity and death. Exercise provocation can be used to assess pulmonary vascular response to exercise and right ventricular contractile reserve. Noninvasive techniques (including cardiopulmonary exercise testing, transthoracic echocardiography, and cardiac MRI) as well as invasive techniques (including right heart catheterization and pressure-volume analysis) may be applied selectively to the screening, diagnosis, and risk stratification of patients with suspected or established PH. Further research is required to determine the role of exercise stress testing in the management of pulmonary vascular disease. This review describes the current understanding of clinical applications of exercise testing in the risk assessment of patients with suspected or established PH.

Identifiants

pubmed: 37061028
pii: S0012-3692(23)00509-3
doi: 10.1016/j.chest.2023.04.013
pmc: PMC10504600
pii:
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

736-746

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007085
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002535
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL144727
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL158507
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL089897
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL136682
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007085
Pays : United States

Informations de copyright

Copyright © 2023 American College of Chest Physicians. All rights reserved.

Références

Circulation. 2008 Nov 18;118(21):2183-9
pubmed: 18981305
Circulation. 2013 Oct 29;128(18):2005-15
pubmed: 24056689
Chest. 1996 Jun;109(6):1566-76
pubmed: 8769513
Int J Chron Obstruct Pulmon Dis. 2015 Jul 14;10:1313-20
pubmed: 26203238
JACC Cardiovasc Imaging. 2016 May;9(5):532-43
pubmed: 26508387
Circulation. 2010 Jul 13;122(2):164-72
pubmed: 20585012
Eur Respir Rev. 2017 Jan 17;26(143):
pubmed: 28096284
J Am Coll Cardiol. 2020 Jan 7;75(1):17-26
pubmed: 31918830
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):329-38
pubmed: 23258478
Eur Respir J. 2010 Jun;35(6):1273-8
pubmed: 19926746
PLoS One. 2013 Sep 05;8(9):e72013
pubmed: 24039732
Eur Respir J. 2016 Apr;47(4):1179-88
pubmed: 26677941
Am J Respir Crit Care Med. 2015 May 1;191(9):1050-7
pubmed: 25710636
Eur J Heart Fail. 2013 Jul;15(7):771-5
pubmed: 23507788
J Am Soc Echocardiogr. 2023 Feb;36(2):259-261
pubmed: 36243216
Eur Respir J. 2013 May;41(5):1031-41
pubmed: 22903957
BMJ Open. 2013 Apr 08;3(4):
pubmed: 23572194
Chest. 2012 Nov;142(5):1166-1174
pubmed: 22556320
J Am Heart Assoc. 2019 Jan 22;8(2):e011464
pubmed: 30646788
Pulm Circ. 2015 Jun;5(2):220-7
pubmed: 26064448
Circulation. 2013 Sep 24;128(13):1470-9
pubmed: 24060943
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545968
Eur Respir J. 2014 May;43(5):1316-25
pubmed: 24177003
Circ Heart Fail. 2019 Jan;12(1):e005512
pubmed: 30616360
Eur Respir J. 2008 Nov;32(5):1371-85
pubmed: 18978137
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H950-H957
pubmed: 29775415
Ann Am Thorac Soc. 2022 Dec;19(12):1977-1985
pubmed: 35802812
Eur Respir J. 2022 Nov 17;60(5):
pubmed: 35618273
J Am Soc Echocardiogr. 2020 Jan;33(1):1-41.e8
pubmed: 31740370
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1444-1456
pubmed: 30219401
Heart. 2012 Feb;98(3):238-43
pubmed: 21917658
Eur Heart J Cardiovasc Imaging. 2016 Nov;17(11):1191-1229
pubmed: 27880640
Circulation. 2013 Mar 12;127(10):1157-64
pubmed: 23479667
Thromb Res. 2013;132(6):659-65
pubmed: 24157082
Circulation. 2001 Jul 24;104(4):429-35
pubmed: 11468205
Heart. 2023 Feb 14;109(5):349-355
pubmed: 35641176
Circ Res. 2006 Sep 29;99(7):675-91
pubmed: 17008597
J Am Heart Assoc. 2022 Feb 15;11(4):e023839
pubmed: 35156392
Eur Respir J. 2021 Jul 22;58(1):
pubmed: 33380512
Pulm Circ. 2020 Oct 2;10(3):2045894020950187
pubmed: 33062259
Am J Respir Crit Care Med. 2022 Dec 1;206(11):1418-1423
pubmed: 35925022
Am J Respir Crit Care Med. 2018 Aug 15;198(4):e15-e43
pubmed: 30109950
Chest. 2010 Aug;138(2):270-8
pubmed: 20418368
J Am Coll Cardiol. 2015 Jul 28;66(4):376-84
pubmed: 26205595
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545974
Chest. 2019 Feb;155(2):297-306
pubmed: 30543808
Physiol Rep. 2017 Apr;5(7):
pubmed: 28373412
Int J Cardiovasc Imaging. 2021 Jul;37(7):2137-2147
pubmed: 33860914
Eur Respir J. 2015 Jan;45(1):139-49
pubmed: 25537560
Am J Respir Crit Care Med. 2003 Mar 1;167(5):735-40
pubmed: 12480614
Eur Respir J. 2014 Sep;44(3):704-13
pubmed: 24833765
J Am Coll Cardiol. 2022 May 3;79(17):1757-1780
pubmed: 35379504
Arthritis Rheumatol. 2019 May;71(5):805-816
pubmed: 30615302
Eur Respir Rev. 2018 May 2;27(148):
pubmed: 29720508
Eur Heart J. 2022 Oct 11;43(38):3618-3731
pubmed: 36017548
Ann Am Thorac Soc. 2017 May;14(5):682-689
pubmed: 28282243
Pulm Circ. 2019 Jul-Sep;9(3):2045894019862435
pubmed: 31218910
Circ Heart Fail. 2014 Nov;7(6):911-7
pubmed: 25190672
Chest. 2020 Jul;158(1):350-358
pubmed: 32173491
Chest. 2020 Oct;158(4):1651-1664
pubmed: 32387520
Eur J Prev Cardiol. 2013 Aug;20(4):605-12
pubmed: 22505056
Pulm Circ. 2018 Jul-Sep;8(3):2045894018787381
pubmed: 29916285
Circulation. 2016 Jun 14;133(24):2413-22
pubmed: 27169739
Circ Heart Fail. 2013 Sep 1;6(5):953-63
pubmed: 23797369
Respirology. 2014 Jul;19(5):675-82
pubmed: 24797365
J Heart Lung Transplant. 2022 Mar;41(3):345-355
pubmed: 34972609
Eur Respir J. 2018 Sep 17;52(3):
pubmed: 30139773
Eur Respir J. 2015 Sep;46(3):738-49
pubmed: 25976688
J Am Heart Assoc. 2015 Mar 23;4(3):e001602
pubmed: 25801760
Circulation. 2018 May 15;137(20):e578-e622
pubmed: 29650544
J Heart Lung Transplant. 2021 Jun;40(6):504-512
pubmed: 33752973
J Physiol. 2020 Jul;598(13):2575-2587
pubmed: 32347547
Circ Heart Fail. 2022 Jan;15(1):e009101
pubmed: 34963308

Auteurs

Lindsay M Forbes (LM)

Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Todd M Bull (TM)

Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Tim Lahm (T)

Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Rocky Mountain Regional VA Medical Center, Aurora, Colorado; Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, Colorado.

Barry J Make (BJ)

Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, Colorado.

William K Cornwell (WK)

Department of Medicine, Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electronic address: william.cornwell@cuanschutz.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH